Beranda › PPOK › Alabama › Birmingham
Uji klinis PPOK di Birmingham, AL
17 studi untuk PPOK mencari peserta di lokasi sekitar Birmingham (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Menerima pesertaFase 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Menerima pesertaFase 2
- University of Alabama at Birmingham, Birmingham
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Menerima pesertaFase 4
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Menerima pesertaFase 2
- Research Site, Birmingham
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Menerima pesertaFase 2
- University of Alabama, Birmingham
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Menerima pesertaFase 1
- University of Alabama at Birmingham, Birmingham
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Menerima pesertaFase 2/3
- University of Alabama at Birmingham Lung Health Center, Birmingham
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Menerima pesertaFase 3
- GC2501 Study Site 106, Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
Menerima pesertaStudi observasional
- Cooper Green Mercy Hospital, Birmingham
Multi-Center Clean Air Randomized Controlled Trial in COPD
Menerima pesertaFase 3
- University of Alabama, Lung Health Center, Birmingham
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
Menerima peserta
- The University of Alabama at Birmingham, Birmingham
SPIROMICS Study of Early COPD Progression (SOURCE)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- University of Alabama at Birmingham, Birmingham
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
Menerima peserta
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
Menerima peserta
- University of Alabama at Birmingham, Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)
Menerima pesertaStudi observasional
- University of Alabama at Birmingham, Birmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
Menerima pesertaFase 4
- University of Alabama at Birmingham, Birmingham
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Menerima peserta
- UAB School of Medicine/Lung Health Center, Birmingham
Uji klinis PPOK di kota lain
- Philadelphia, PA23 studi
- Miami, FL18 studi
- Boston, MA17 studi
- Houston, TX15 studi
- Orlando, FL15 studi
- Baltimore, MD14 studi
- Chicago, IL14 studi
- Dallas, TX12 studi
- Pittsburgh, PA12 studi
- New York City, NY11 studi
- Ann Arbor, MI10 studi
- Los Angeles, CA9 studi
Studi lain di Birmingham
- Kanker (semua jenis)30 studi
- Kanker Payudara24 studi
- Obesitas23 studi
- Kanker Ovarium23 studi
- Kanker Paru Non-Sel Kecil22 studi
- Leukemia Mieloid Akut21 studi
- Mieloma Multipel18 studi
- Penyakit Kardiovaskular17 studi
- Kelebihan Berat Badan16 studi
- Kanker Endometrium16 studi
- Diabetes Tipe 216 studi
- Fibrosis Kistik16 studi
Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.